Paper39652176
Treatment of cancer-associated fibroblast-like cells with celecoxib enhances the anti-cancer T helper 1/Treg responses in breast cancer.
Samoudi A and 5 others. Naunyn Schmiedebergs Arch Pharmacol, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Treatment of cancer-associated fibroblast-like cells with celecoxib enhances the anti-cancer T helper 1/Treg responses in breast cancer. Papers, record 39652176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39652176
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment of cancer-associated fibroblast-like cells with celecoxib enhances the anti-cancer T helper 1/Treg responses in breast cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Celecoxib | Major topic |
| Breast Neoplasms | Major topic |
| Cancer-Associated Fibroblasts | Major topic |
| Cyclooxygenase 2 Inhibitors | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Th1 Cells | Major topic |
| Antineoplastic Agents | Major topic |
| Humans | |
| Female | |
| Cytokines | |
| Cyclooxygenase 2 | |
| Middle Aged | |
| Dinoprostone | |
| Tumor Microenvironment | |
| Coculture Techniques |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| IR.KMU.REC.1398.257 | Kerman univ | PubMed |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7836930 | Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. | J Exp Med | 1995 | https://conductscience.org/library/papers/7836930 | PubMed |
| 2 | 30140269 | Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation. | Front Immunol | 2018 | https://conductscience.org/library/papers/30140269 | PubMed |
| 3 | 32810447 | The tumor microenvironment. | Curr Biol | 2020 | https://conductscience.org/library/papers/32810447 | PubMed |
| 4 | 28096371 | COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28096371 | PubMed |
| 5 | 1845802 | Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. | J Immunol | 1991 | https://conductscience.org/library/papers/1845802 | PubMed |
| 6 | 29483289 | Prostaglandin E2 Induction Suppresses the Th1 Immune Responses in Cattle with Johne's Disease. | Infect Immun | 2018 | https://conductscience.org/library/papers/29483289 | PubMed |
| 7 | 8759715 | Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas. | J Immunol | 1996 | https://conductscience.org/library/papers/8759715 | PubMed |
| 8 | 34445735 | Failure of Immunotherapy-The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445735 | PubMed |
| 9 | 31838289 | New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation. | Bioorg Chem | 2020 | https://conductscience.org/library/papers/31838289 | PubMed |
| 10 | 28231855 | COX-2 expression positively correlates with PD-L1 expression in human melanoma cells. | J Transl Med | 2017 | https://conductscience.org/library/papers/28231855 | PubMed |
| 11 | 16996805 | Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia. | Clin Gastroenterol Hepatol | 2006 | https://conductscience.org/library/papers/16996805 | PubMed |
| 12 | 17483367 | Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. | Cancer Res | 2007 | https://conductscience.org/library/papers/17483367 | PubMed |
| 13 | 27375620 | Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units. | Front Immunol | 2016 | https://conductscience.org/library/papers/27375620 | PubMed |
| 14 | 21907301 | COX-2 and PGE2-dependent immunomodulation in breast cancer. | Prostaglandins Other Lipid Mediat | 2011 | https://conductscience.org/library/papers/21907301 | PubMed |
| 15 | 11278747 | Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11278747 | PubMed |
| 16 | 35675777 | PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment. | Cell Rep | 2022 | https://conductscience.org/library/papers/35675777 | PubMed |
| 17 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 18 | 34178680 | The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition. | Front Oncol | 2021 | https://conductscience.org/library/papers/34178680 | PubMed |
| 19 | 19136477 | The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. | Carcinogenesis | 2009 | https://conductscience.org/library/papers/19136477 | PubMed |
| 20 | 22534817 | Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer. | J Thorac Oncol | 2012 | https://conductscience.org/library/papers/22534817 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41890735 | Aging modulation of the immune system and immunotherapy efficacy in cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/41890735 | PubMed |
| 41383482 | Celecoxib in oncology: targeting the COX-2/PGE2 axis to reprogram the tumor immune microenvironment and enhance multimodal therapy. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41383482 | PubMed |
| 40551209 | Paracrine signaling in cancer-associated fibroblasts: central regulators of the tumor immune microenvironment. | J Transl Med | 2025 | https://conductscience.org/library/papers/40551209 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACTA1 | 58 | PubTator's text mining | https://conductscience.org/library/genes/58 | NCBI Gene |
| FAP | 2191 | PubTator's text mining | https://conductscience.org/library/genes/2191 | NCBI Gene |
| FOXP3 | 50943 | PubTator's text mining | https://conductscience.org/library/genes/50943 | NCBI Gene |
| GATA3 | 2625 | PubTator's text mining | https://conductscience.org/library/genes/2625 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL4 | 3565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| TBX21 | 30009 | PubTator's text mining | https://conductscience.org/library/genes/30009 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39652176
GET https://conductscience.org/api/papers/v1/39652176/references?page=2